Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Heritage Cannabis in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.01.
Current Consensus is
N/A
The current consensus among 0 investment analysts is to n/a stock in Heritage Cannabis. This N/A consensus rating has held steady for over two years.
Heritage Cannabis Holdings Corp., through its subsidiaries, operates as a cannabinoid company in Canada and the United States. It focuses on extraction and the creation of extract and extract-derivative products and brands for adult use and cannabis-based medical solutions. The company offers medicinal-grade cannabis formulations for the pharmaceutical, recreational, and cosmeceutical markets under the Purefarma brand; CBD, indica, sativa, and hybrid concentrates under the Pura Vida brand; tetrahydrocannabinol concentrates under the Premium 5 brand; concentrates under the RAD brand; skin care and wellness products under the feelgood. brand; hemp formulation under the ArthroCBD brand; and oral capsules, sublingual filmstrips, and topically administered products in the form of gels and creams under the CB4 brand. It also provides various cannabis products under the Thrifty brand. The company was formerly known as Umbral Energy Corp. and changed its name to Heritage Cannabis Holdings Corp. in January 2018. Heritage Cannabis Holdings Corp. was incorporated in 2007 and is headquartered in Toronto, Canada.
Read More